Silencing of GLS, GOT2, and ASNS dramatically reduced SOX12-mediated CRC cell proliferation, migration, and invasion, whereas GLS, GOT2, and ASNS overexpression attenuated the decrease in CRC cell aggressiveness induced by SOX12 knockdown. The gene discussed is GOT2; the disease is colorectal carcinoma.